CONTRATOS ARTICULO 60 LOSU
Contract
Papel de Ascl1 en la Heterogeneidad Celular del Cáncer de Pulmón de Células Pequeñas (Sclc)
Funder:
IDP DISCOVERY PHARMA
date_range
Duration: from 08 June 2022 to 07 December 2022
(6 months)
euro
12,288.89 EUR
Of National scope. With a Private character.
Researchers
Jose Neptuno
Rodriguez Lopez
Leader